Concepedia

Tamanna Haque

TH

5

Publications

105

Citations

5

H-Index

2019

Active since

Affiliations

Massachusetts General Hospital(Current)

The Ohio State University

Heinrich Heine University Düsseldorf

Clinica Universidad de Navarra

Hospital Universitario Virgen del Rocío

Tamanna Haque is an author at Massachusetts General Hospital specializing in immunology, hematology, and epigenetics.

ORCID

Top concepts

Publications per year

2019–2025

5

Publications

5

PI3K alpha and delta promote hematopoietic stem cell activation

Shayda Hemmati, Taneisha Sinclair, Meng Tong et al. · JCI Insight · 2019 · 40 citations · Full text

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes

Tamanna Haque, Félix López Cadenas, Blanca Xicoy et al. · Blood · 2021 · 19 citations

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Tamanna Haque, Félix López Cadenas, Blanca Xicoy et al. · Leukemia Research · 2023 · 18 citations

, , +7

Incidence of Venous Thrombosis After Peg-Asparaginase in Adolescent and Young Adults with Acute Lymphoblastic Leukemia

Brynne Underwood, Qiuhong Zhao, Alison R. Walker et al. · International Journal of Hematologic Oncology · 2020 · 16 citations · Full text

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025

P Greenberg, Richard M. Stone, Yasmin Abaza et al. · Journal of the National Comprehensive Cancer Network · 2025 · 12 citations · Full text

Rows per page

1–5 of 5